Mitchell Lee’s Post

Life science companies could make an additional $180 billion globally by fully adopting digital solutions to drive innovation. Speaking to Genetic Engineering & Biotechnology News, Michael Barnes, Lead Solutions Consultant at IDBS, explains that streamlining technology transfers between process development and manufacturing is key: 💬 "If it's more transparent and easier to access from the manufacturing side, then that leads to a ton of cost savings." Read the article: https://ow.ly/i8Lp50TT9Kv #biotechnology #digitalstrategy #DanaherNews

Technology transfer between process development and manufacturing is one of the hardest processes for teams to accomplish during drug development. Learn how to simplify with IDBS: #DanaherLifeSciences #databackbone #digitaltransformation

In the world of biotechnology, where progress is driven by the smallest components of life, seeing beyond the surface can lead to revolutionary breakthroughs. At DrugSense Analytics, we believe that every data point has the potential to unlock groundbreaking treatments. Ready to revolutionize the future of medicine with us? 🌐 www.drugsenseanalytics.com 📧 [email protected] 📞+91 736 2968 185 Let's transform molecular data into groundbreaking discoveries! 💡 #Cheminformatics #BiotechInnovation #DrugDiscovery #MolecularData #DataAnalytics #drugsense #DrugDiscovery #DataAnalytics #BiotechInnovation #PrecisionMedicine #LifeSciences #Bioinformatics #Cheminformatics

Earlier this year at SynBioBeta 2024, Ansa Biotechnologies, Inc. unveiled a groundbreaking manufacturing process that leverages the most powerful enzymatic synthesis system ever created. This innovation is set to revolutionize the industry and bring immense benefits to customers worldwide. 👉 Watch the clip to learn more about how Ansa is pushing the boundaries of synthetic biology. #SynBioBeta2024 #SyntheticBiology #Innovation

Join Synonym, in collaboration with EV Biotech, Vectron Biosolutions, SynBioBeta and Enduro Genetics, for an insightful discussion on the critical role of strain engineering in the commercialization of bioproducts. Synonym and BCG’s recent report reveals that economies of scale alone are not sufficient for commercializing industrial bioproducts. Optimized strains designed for scale are pivotal for unlocking the massive potential of biomanufacturing in the coming decades. Our expert panel will explore the significance of strain optimization and its impact on increasing productivity, enhancing product quality, and achieving cost efficiency in biomanufacturing processes. 📅 Date: July 17, 2024 🕒 Time: 4pm to 5pm CET 📍 Register here: https://lnkd.in/ey4VDbzA Hear from an incredible lineup of industry leaders, and experts: Crystal Bleecher, PE VP (Science & Engineering) at @Synonym Christian Munch CEO at Enduro Genetics Linda Dijkshoorn CCO and Founder at EV Biotech Trond Erik Vee Aune CEO at Vectron Biosolutions AS Fiona Mischel (moderator), Director (International) at SynBioBeta Don't miss out on this opportunity to shape the future of sustainable development through biomanufacturing. To register, please visit this link. We look forward to seeing you there! #bioeconomy #biomanufacturing #sustainability #innovation #webinar #strainengineering #strainoptimization #fermentation #precisionfermentation

I had the pleasure of attending the Maryland Tech Council’s Bio Innovation Conference last Thursday. The event brought together thought leaders, innovators, and industry professionals from across the life sciences sector to explore the latest advancements shaping the future of healthcare and biotechnology. Among the highlights was the insightful presentation on AI in the life sciences industry. It is exciting to see how AI-powered solutions are accelerating research. #marylandtechcouncil #bioinnovation #clinicalresearch #lifescience

Join us next Tuesday, 24 September, 2024, for our webinar 'Enabling High-Throughput Screening and Characterization of Targeted Protein Degraders'. 🧪💊 Experts from Promega and Evotec will discuss the development of high-throughput targeted protein degradation platforms using HiBiT technology and the assessment of cellular protein-protein or protein-small molecule interactions by NanoBRET technology, including binary engagement, ternary complex formation, and ubiquitination. Learn about: ✔️ HiBiT and NanoBRET technologies and Promega assays for screening and interrogating cellular mechanisms of degraders ✔️ Evotec’s high-throughput screening platforms and workflow ✔️ How Evotec applied these platforms for robust identification and characterization of degraders Register now ➡️ https://bit.ly/47wCKB6 #hibit #nanobret #screening #targetedproteindegradation #webinar #lifesciences #biotech

Making AAV is crazy expensive. But producing it in plants could fix that. (While also being more scalable and better for the environment) Many thanks to Daniel G., CEO of Cirsium Biosciences, for breaking down the approach his team is taking. I’m excited to see how this strategy could benefit our industry (and patients). Any thoughts on this? Drop them in the comments. #genetherapy #innovation #biotechnology

“Hot Ones”-style interview with Dean Johnson https://lnkd.in/gDgczuu9 The post “Hot Ones”-style interview with Dean Johnson appeared first on Life Sciences. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News

SFBN Feed: Scientists Discover First Nitrogen-Fixing Organelle https://lnkd.in/g5QisTz5 The post Scientists Discover First Nitrogen-Fixing Organelle appeared first on Berkeley Lab News Center. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #BayArea #SanFrancisco #Biotech #Lifescience #News